Lyra Therapeutics, Inc. Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation
Depreciation expense
Impairment of property and equipment
Write-off of deferred financing costs
Impairment of right-of-use assets
Gain on sale of property and equipment
Net amortization of discount on short-term investments
Changes in operating assets and liabilities
Prepaid expenses and other current assets
Operating lease right-of-use assets
Other assets
Accounts payable
Accrued expenses and other current liabilities
Restructuring liability
Operating lease liabilities
Deferred revenue
Net cash used in operating activities
Cash flows from investing activities:
Purchases of property and equipment
Proceeds from maturities of investments
Proceeds from the sale of property and equipment
Purchases of short-term investments
Maturity of short-term investments
Net cash (used in) provided by investing activities
Cash flows from financing activities:
Proceeds from sale of common stock and pre-funded warrants
Proceeds from sale of common stock, warrants and pre-funded warrants
Payment of deferred offering costs
Proceeds from exercise of stock options
Net cash provided by financing activities

Net (decrease) increase in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash, beginning of period
Cash, cash equivalents and restricted cash, end of period
Supplemental disclosure of non-cash financing and investing activities:
Property and equipment purchases included in accounts payable and accrued expenses
Other Assets Included in Accounts Payable and Accrued Expenses
Prepaid expenses for right-of-use asset included in operating lease liabilities
Modification of lease agreement
Deferred offering costs included in accounts payable and accrued expense
Right-of-use asset in exchange for lease liability
Other assets included in accounts payable and other current liabilities
Right of Use Asset in Exchange for Lease Liability
Other assets included in accounts payable

Comments